𝔖 Bobbio Scriptorium

✦ LIBER ✦

Hastings first-half results improve despite market weakness

Book ID: 104377520
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 146 KB
Volume: 2002
Category: Article
ISSN: 1350-4789
DOI: 10.1016/s1350-4789(02)10040-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strong oil, gas market boosts wood's fir

Strong oil, gas market boosts wood's first half results

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Adding irinotecan to first-line gemcitab

Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer: Abstracted from: Rocha Lima CM, Green MR, Rotche R et al. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumour response rate. J Clin Oncol 2004;22:3776–83.

✍ Desmond Yip; David Goldstein 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 103 KB